查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575016

梅毒免疫分析诊断市场，按测试类型、样本类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Syphilis Immunoassay Diagnostic Market, By Test Type, By Sample Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年梅毒免疫分析诊断市场规模为291,0932万美元，2024年至2032年复合年增长率为7.60%。

梅毒免疫分析诊断市场-市场动态

对准确和快速诊断测试的需求激增推动梅毒免疫分析诊断市场的成长

对梅毒进行准确、快速的诊断测试的日益紧迫性极大地影响了免疫分析诊断市场。世界卫生组织报告称，全球梅毒发病率上升，特别是在高风险族群中，凸显了有效筛检的必要性。创新的测试方法，例如即时检测，可在 30 分钟内提供结果，从而改善患者管理和治疗结果。在美国，疾病管制与预防中心强调，从 2014 年到 2018 年，梅毒病例增加了近 75%，促使医疗保健提供者优先考虑快速检测解决方案。性传染感染的整体上升进一步推动了对可靠诊断测试的需求，导致主要医疗保健公司增加了研发投资。这一趋势强调了快速诊断能力在控制梅毒传播和改善公共卫生应变方面的关键作用。

梅毒免疫分析诊断市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 7.60% 左右的复合年增长率成长

根据测试类型细分，预计即时 (POC) 测试将在 2023 年显示最大的市场份额

根据样本类型细分，血液是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

梅毒免疫分析诊断市场-細項分析：

全球梅毒免疫分析诊断市场根据测试类型、样本类型、最终用户和地区进行细分。

根据测试类型，市场分为四类：密螺旋体测试、非密螺旋体测试、护理点 (POC) 测试和自动免疫测定。由于即时检测 (POC) 检测快速且易于使用，预计将占据主导地位。紧随其后的是密螺旋体测试、非密螺旋体测试和自动免疫测定，每种测试在诊断方面都有独特的优势。

根据样本类型，市场分为三类：血液、血清和血浆。由于血液样本广泛且易于采集，因此预计将领先。以下是血清样本，因其在测试中的稳定性而受到青睐，以及血浆样本，也常用于诊断。

梅毒免疫分析诊断市场-地理洞察

梅毒免疫分析诊断市场表现出显着的地理差异，其中北美由于其先进的医疗基础设施和性传播感染的高盛行率而处于领先地位。疾病管制与预防中心注意到梅毒病例激增，促使采取措施加强筛检和检测能力。在欧洲，英国和德国等国家正在投资创新诊断技术，欧洲疾病预防与控制中心强调早期检测和治疗的重要性。在意识提高和医疗保健改善的推动下，亚太地区正在快速成长；例如，印度实施了国家计画来解决高风险族群的梅毒筛检问题。拉丁美洲也在取得进展，巴西报告了将快速诊断测试纳入公共卫生策略的努力。同时，中东和非洲面临独特的挑战，包括资源限制，但在旨在减轻性传染感染负担的国际卫生组织的推动下，它们开始采用更有效的检测方法。

梅毒免疫分析诊断市场-竞争格局：

梅毒免疫分析诊断市场的竞争格局显示了各个地区的重要活动。北美以雅培实验室 (Abbott Laboratories) 和罗氏 (Roche) 等主要企业领跑，它们正在投资先进的免疫分析技术，以提高梅毒检测的准确性和速度。美国性健康协会报告称，快速检测方法对于控制梅毒疫情至关重要。在欧洲，西门子医疗和生物梅里埃等公司正在欧盟改善性传染感染检测和治疗方案措施的支持下推动创新。在亚太地区，Fujirebio 和 Tecan 等公司正在扩大其市场份额，其中日本和澳洲强调全面的筛检计画。拉丁美洲也正在成为一个竞争舞台，当地公司正在与国际公司合作，以改善获得诊断测试的机会，这反映了世界卫生组织对减少梅毒盛行率的关注。在中东和非洲，在非政府组织旨在提高性健康意识的倡议的支持下，随着价格实惠的检测试剂盒的推出，市场正在不断发展。

最新进展：

2024 年 8 月，NowDiagnostics 的 First to Know(R) 梅毒检测获得 FDA 的非处方使用从头行销授权。这种免疫分析诊断使个人可以在家中检测梅毒，从而提高感染的可及性和早期检测能力。

2021 年 11 月，MedAccess、CHAI 和 SD Biosensor 宣布建立合作伙伴关係，在 100 多个低收入和中等收入国家以不到 1 美元的价格提供梅毒和爱滋病毒双重快速检测。此测试可以快速诊断，改善孕产妇健康并减少与梅毒相关的死产。

目录

第 1 章：梅毒免疫分析诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 梅毒免疫分析诊断市场片段（按测试类型）
    • 按样本类型分類的梅毒免疫分析诊断市场片段
    • 最终用户的梅毒免疫分析诊断市场片段
    • 按国家/地区分類的梅毒免疫分析诊断市场片段
    • 按地区分類的梅毒免疫分析诊断市场片段
  • 竞争洞察

第 3 章：梅毒免疫分析诊断主要市场趋势

  • 梅毒免疫分析诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 梅毒免疫分析诊断市场限制
    • 市场限制影响分析
  • 梅毒免疫分析诊断市场机会
  • 梅毒免疫分析诊断市场未来趋势

第 4 章：梅毒免疫分析诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：梅毒免疫分析诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：梅毒免疫分析诊断市场格局

  • 梅毒免疫分析诊断市占率分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：梅毒免疫分析诊断市场 - 按测试类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 密螺旋体测试
    • 非密螺旋体测试
    • 即时护理 (POC) 测试
    • 自动免疫分析

第 8 章：梅毒免疫分析诊断市场 - 依样本类型

  • 概述
    • 按样本类型分類的细分市场占有率分析
    • 血
    • 血清
    • 电浆

第 9 章：梅毒免疫分析诊断市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊断实验室
    • 血库
    • 社区诊所

第 10 章：梅毒免疫分析诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美梅毒免疫分析诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按样本类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲梅毒免疫分析诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模和预测（按样本类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区梅毒免疫分析诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按测试类型）
    • 亚太地区市场规模与预测（依样本类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲梅毒免疫分析诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按测试类型）
    • 拉丁美洲市场规模和预测（按样本类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲梅毒免疫分析诊断主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按测试类型）
    • 中东和非洲市场规模及预测（按样本类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-梅毒免疫分析诊断产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • Beckman Coulter, Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Cardinal Health, Inc.
    • Cepheid Inc. (Danaher)
    • Chembio Diagnostics, Inc.
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • OraSure Technologies, Inc.
    • Qiagen NV
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech plc
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4011

REPORT HIGHLIGHT

The Syphilis Immunoassay Diagnostic Market size was valued at USD 29,109.32 million in 2023, expanding at a CAGR of 7.60% from 2024 to 2032.

The Syphilis Immunoassay Diagnostic Market encompasses various testing methods used to detect syphilis infections, which remain a significant public health concern globally. With rising rates of syphilis, particularly among certain demographics, the demand for accurate and rapid diagnostic tests has surged. Increased awareness and education regarding sexually transmitted infections (STIs) have contributed to higher testing rates. Moreover, government initiatives aimed at reducing STI prevalence have bolstered market growth. However, challenges such as the availability of alternative testing methods and the stigma surrounding STIs may restrain market expansion. Opportunities lie in the development of novel immunoassay technologies and point-of-care testing solutions, which can enhance accessibility and facilitate timely treatment. For instance, the CDC reported a 20% increase in reported syphilis cases in recent years, highlighting the urgent need for improved diagnostic tools and public health interventions.

Syphilis Immunoassay Diagnostic Market- Market Dynamics

Surge in Demand for Accurate and Rapid Diagnostic Tests Propels Growth in the Syphilis Immunoassay Diagnostic Market

The growing urgency for accurate and rapid diagnostic tests for syphilis has significantly influenced the market for immunoassay diagnostics. The World Health Organization reported that global syphilis rates have risen, particularly among high-risk populations, underscoring the need for effective screening. Innovative testing methods, such as point-of-care tests, provide results in under 30 minutes, enhancing patient management and treatment outcomes. In the U.S., the Centers for Disease Control and Prevention highlighted that syphilis cases increased by nearly 75% from 2014 to 2018, prompting healthcare providers to prioritize swift testing solutions. The rise in sexually transmitted infections overall has further driven the demand for reliable diagnostic tests, leading to increased investments in research and development by major healthcare companies. This trend emphasizes the critical role of rapid diagnostic capabilities in controlling the spread of syphilis and improving public health responses.

Syphilis Immunoassay Diagnostic Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.60% over the forecast period (2024-2032)

Based on Test Type segmentation, Point-of-care (POC) Tests were predicted to show maximum market share in the year 2023

Based on Sample Type segmentation, Blood was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Syphilis Immunoassay Diagnostic Market- Segmentation Analysis:

The Global Syphilis Immunoassay Diagnostic Market is segmented on the basis of Test Type, Sample Type, End-User, and Region.

The market is divided into four categories based on Test Type: Treponemal Tests, Non-Treponemal Tests, Point-of-Care (POC) Tests, and Automated Immunoassays. Point-of-care (POC) Tests are predicted to dominate due to their rapid results and ease of use. Following closely are Treponemal Tests, Non-Treponemal Tests, and Automated Immunoassays, each offering unique benefits in diagnostics.

The market is divided into three categories based on Sample Type: Blood, Serum, and Plasma. Blood samples are expected to lead due to their widespread availability and ease of collection. Following are Serum samples, favored for their stability in testing, and Plasma samples, which are also commonly utilized in diagnostics.

Syphilis Immunoassay Diagnostic Market- Geographical Insights

The Syphilis Immunoassay Diagnostic Market exhibits significant geographical variation, with North America leading due to its advanced healthcare infrastructure and high prevalence of sexually transmitted infections. The Centers for Disease Control and Prevention noted a surge in syphilis cases, prompting initiatives to enhance screening and testing capabilities. In Europe, countries like the UK and Germany are investing in innovative diagnostic technologies, with the European Centre for Disease Prevention and Control emphasizing the importance of early detection and treatment. Asia-Pacific is witnessing rapid growth, driven by increasing awareness and healthcare improvements; for instance, India has implemented national programs to address syphilis screening among high-risk populations. Latin America is also making strides, with Brazil reporting efforts to integrate rapid diagnostic tests into public health strategies. Meanwhile, the Middle East and Africa face unique challenges, including resource constraints, but are beginning to adopt more effective testing methods, spurred by international health organizations aiming to reduce the burden of sexually transmitted infections.

Syphilis Immunoassay Diagnostic Market- Competitive Landscape:

The competitive landscape of the Syphilis Immunoassay Diagnostic Market showcases significant activity across various regions. North America leads with key players like Abbott Laboratories and Roche, which are investing in advanced immunoassay technologies to enhance accuracy and speed in syphilis testing. The American Sexual Health Association has reported that rapid testing methods are crucial in controlling syphilis outbreaks. In Europe, companies such as Siemens Healthineers and BioMerieux are driving innovation, supported by the European Union's initiatives to improve STI testing and treatment protocols. In the Asia-Pacific region, firms like Fujirebio and Tecan are expanding their market presence, with Japan and Australia emphasizing comprehensive screening programs. Latin America is also becoming a competitive arena, where local companies are partnering with international firms to improve access to diagnostic tests, reflecting the World Health Organization's focus on reducing syphilis prevalence. In the Middle East and Africa, the market is evolving with the introduction of affordable testing kits, supported by initiatives from non-governmental organizations to bolster sexual health awareness.

Recent Developments:

In August 2024, NowDiagnostics' First to Know(R) syphilis test received FDA de novo marketing authorization for over-the-counter use. This immunoassay diagnostic allows individuals to test for syphilis at home, enhancing accessibility and early detection of the infection.

In November 2021, MedAccess, CHAI, and SD Biosensor announced a partnership to provide a dual rapid test for syphilis and HIV for under $1 in over 100 low- and middle-income countries. This test enables quick diagnosis, improving maternal health and reducing stillbirths linked to syphilis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson, and Company
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • Cepheid Inc. (Danaher)
  • Chembio Diagnostics, Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • OraSure Technologies, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
  • Others

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Treponemal Tests
  • Non-Treponemal Tests
  • Point-of-Care (POC) Tests
  • Automated Immunoassays

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Serum
  • Plasma

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Community Clinics

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Syphilis Immunoassay Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Syphilis Immunoassay Diagnostic Market Snippet by Test Type
    • 2.1.2. Syphilis Immunoassay Diagnostic Market Snippet by Sample Type
    • 2.1.3. Syphilis Immunoassay Diagnostic Market Snippet by End-User
    • 2.1.4. Syphilis Immunoassay Diagnostic Market Snippet by Country
    • 2.1.5. Syphilis Immunoassay Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Syphilis Immunoassay Diagnostic Key Market Trends

  • 3.1. Syphilis Immunoassay Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Syphilis Immunoassay Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Syphilis Immunoassay Diagnostic Market Opportunities
  • 3.4. Syphilis Immunoassay Diagnostic Market Future Trends

4. Syphilis Immunoassay Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Syphilis Immunoassay Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Syphilis Immunoassay Diagnostic Market Landscape

  • 6.1. Syphilis Immunoassay Diagnostic Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Syphilis Immunoassay Diagnostic Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Treponemal Tests
    • 7.1.3. Non-Treponemal Tests
    • 7.1.4. Point-of-Care (POC) Tests
    • 7.1.5. Automated Immunoassays

8. Syphilis Immunoassay Diagnostic Market - By Sample Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
    • 8.1.2. Blood
    • 8.1.3. Serum
    • 8.1.4. Plasma

9. Syphilis Immunoassay Diagnostic Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Blood Banks
    • 9.1.5. Community Clinics

10. Syphilis Immunoassay Diagnostic Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Syphilis Immunoassay Diagnostic Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Syphilis Immunoassay Diagnostic Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Beckman Coulter, Inc.
    • 11.2.3. Becton, Dickinson and Company
    • 11.2.4. bioMerieux S.A.
    • 11.2.5. Bio-Rad Laboratories, Inc.
    • 11.2.6. Cardinal Health, Inc.
    • 11.2.7. Cepheid Inc. (Danaher)
    • 11.2.8. Chembio Diagnostics, Inc.
    • 11.2.9. DiaSorin S.p.A.
    • 11.2.10. F. Hoffmann-La Roche AG
    • 11.2.11. Hologic, Inc.
    • 11.2.12. OraSure Technologies, Inc.
    • 11.2.13. Qiagen N.V.
    • 11.2.14. Siemens Healthineers AG
    • 11.2.15. Thermo Fisher Scientific Inc.
    • 11.2.16. Trinity Biotech plc
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us